The Skin Cancer Conference 2011 - Speakers and presenters

We have selected a variety of expert international and national clinicians, researchers, specialists and generalists, with the aim of providing a stimulating educational program.

Presenters include:


Professor Giuseppe Argenziano Department of Dermatology Second University of Naples Naples, Italy	Professor Iris Zalaudek Department of Dermatology Medical University of Graz Graz, Austria	Dr Adam Riker Medical Director of Cancer Services Ochsner Health System New Orleans, USA	Professor Ian Frazer Director of the Diamantina Institute Research Leader, Immunotherapy Group University of Queensland

Professor Scott Menzies Professor of Medicine, Central Clinical School, Discipline of Dermatology and Director of Sydney Melanoma Diagnostic Centre at the University of Sydney.	Dr Mark Smithers Associate Professor of Surgery University of Queensland Director, Upper GI, Soft Tissue Unit Princess Alexandra Hospital Brisbane Australia	Dr Simon Clark Dermatopathologist Senior Lecturer School of Medicine University of Queensland	Professor David Wilkinson Dean of Medicine and Head School of Medicine University of Queensland Brisbane Australia

Dr Cliff Rosendahl Senior Lecturer School of Medicine University of Queensland	Professor Adele Green AC Head of the Queensland Institute of Medical Research Cancer and Population Studies Royal Brisbane Hospital	Dr Richard Williamson Dermatopathologist Sullivan & Nicholades Pathology Brisbane Australia	Dr Di Eley Senior Research Fellow School of Medicine University of Queensland Brisbane Australia

Professor Peter Soyer Head of Dermatology School of Medicine University of Queensland	Assoc Professor David Whiteman Cancer and Population Studies Queensland Institute of Medical Research Royal Brisbane Hospital	Professor Peter Hersey Professor of Oncology at the University of Newcastle Chairman of the Melanoma and Skin Cancer Group of the Clinical Oncology Society of Australia

Professor Iris Zalaudek

Professor Iris Zalaudek graduated from the Karl Franzens University of Graz, Austria. She obtained a diploma in the specialisation in Dermatology and Venereology in 2003 at the Department of Dermatology, of the Medical University of Graz, Austria. Her main research field is dermato-oncology and dermoscopy. She has more than 60 scientific published articles in international peer reviewed journals with special emphasis on dermoscopy and oncology. She was clinical investigator for two multicentre trials researching new therapies for advanced melanoma.

Professor Giuseppe Argenziano

Professor of Dermatology in the Department of Dermatology, Second University of Naples, Italy. His main field of research is in the use of new technologies for improving the diagnostic accuracy of pigmented lesions and early recognition of melanoma. He is author of numerous scientific articles and three books on dermoscopy. Professor Argenziano is the General Secretary of the International Dermoscopy Society.

Dr Simon Clark MBChB FRCPA

Specialist Histopathologist and Dermatopathologist Honorary Senior Lecturer University of Queensland, Australia Simon Clark has over 20 years of experience in dermatopathology education, training registrars in dermatology, pathology and plastic surgery and more recently in GP education. He is author of many pathology papers in peer reviewed journals, holds a fellowship of the Royal College of Pathologists of Australia and is a member of the International Society of Dermatopathology.

Professor David Wilkinson

Head of the School of Medicine and Professor of Primary Care University of Queensland, Australia David Wilkinson is a practicing GP with a special interest in skin cancer and a specialist in public health medicine. He led the development of the University of Queensland Master of Medicine (Skin Cancer) program and holds an award for excellence in teaching and learning from the Carrick Institute, Australia's highest such award.

Dr Adam I. Riker, M.D., F.A.C.S.

Adam I. Riker, M.D., F.A.C.S., is the Medical Director of Cancer Services for Ochsner Health System and the Director of the Cancer Screening Program. A major emphasis of this position has been to integrate the Cancer Services on a system-wide basis, developing the growth of multidisciplinary cancer programs. Additionally, a major objective of the Ochsner Cancer Institute has been to further enhance the expansion and accrual of patients to the active Community Clinical Oncology Program (CCOP) supported by the National Institutes of Health, National Cancer Institute.

Dr Mark Smithers

Director, Upper GI, Soft Tissue Unit Princess Alexandra Hospital

Associate Professor, Department of Surgery, The University of Queensland
Chairman, Melanoma Clinic, Princess Alexandra Hospital, Brisbane; Chairman, Queensland Melanoma Project and
Medical Director, Melanoma Patients Australia.

The Queensland Melanoma Project co-ordinates trials ranging from Phase I studies of new therapies to multicentre Phase III trials for patients with locally advanced primary disease through to patients with stage IV metastatic melanoma.

Dr Cliff Rosendahl MBBS FSCCANZ

Lecturer School of Medicine, The University of Qld

Current Vice President SCCANZ
Director Skin Cancer Audit Research Database (SCARD)
Co-editor SCCANZ Skin Cancer Blog
Author and co-author of several published papers in peer-reviewed international journals
Invited presenter at several international venues on skin cancer and melanoma diagnosis
Over 30 years experience in General Practice including 7 years as a rural practitioner and 15 years forensic practice as Government Medical Officer (Qld)